ARCHIVES

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA

July 3, 1981

Cancer Letter Adds Associate Editor

July 19, 1985

Potti Claimed Rhodes Credential in Bio Submitted for DOD Funding

July 30, 2010

Nimer to Lead Miami Sylvester Cancer Center

March 9, 2012

In Brief: Reagan Okays Reauthorization; Harold Freeman ACS President, Robert Schweitzer President Elect

November 11, 1988

ASCO Urges Steps to Eliminate Cancer Care Disparities

May 22, 2009